Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
CVST-VITT in lage-, midden- en hoge-inkomenslanden
sep 2023 | Neuro-vasculair, Vaccinatie, Virale infecties